94 related articles for article (PubMed ID: 11219206)
1. [What is your diagnosis? Relative hypergonadotrophic ovarian insufficiency after chemotherapy for Hodgkin disease].
Zanetti Dällenbach R; De Geyter C
Praxis (Bern 1994); 2001 Jan; 90(3):47-9. PubMed ID: 11219206
[No Abstract] [Full Text] [Related]
2. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
[TBL] [Abstract][Full Text] [Related]
3. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Franke HR; Smit WM; Vermes I
Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
[TBL] [Abstract][Full Text] [Related]
4. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
Peccatori F; Demeestere I
Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
[No Abstract] [Full Text] [Related]
5. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
[TBL] [Abstract][Full Text] [Related]
6. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients.
Huser M; Crha I; Ventruba P; Hudecek R; Zakova J; Smardova L; Kral Z; Jarkovsky J
Hum Reprod; 2008 Apr; 23(4):863-8. PubMed ID: 18258763
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and clinical status of premature ovarian failure].
Kovachev E; Kozovski I; Markova V; Andonov M; Cherneva S; Aleksandrov K
Akush Ginekol (Sofiia); 2003; 42(4):34-8. PubMed ID: 14577366
[TBL] [Abstract][Full Text] [Related]
8. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract][Full Text] [Related]
9. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
[TBL] [Abstract][Full Text] [Related]
10. [Pregnancy in a patient with premature ovarian failure secondary to chemotherapy].
Triantafilo Y; Arteaga E; Duque G; Fernández C; Grebe G
Rev Med Chil; 1991 Jan; 119(1):60-3. PubMed ID: 1824146
[TBL] [Abstract][Full Text] [Related]
11. Premature ovarian failure in the early age 20s: 3 case reports.
Berhan Y; Lakew Z
Ethiop Med J; 2005 Oct; 43(4):291-5. PubMed ID: 16523651
[TBL] [Abstract][Full Text] [Related]
12. [The prevention of reproductive disorders occurring during the chemotherapy of women of child-bearing age suffering from Hodgkin's disease].
Ignashina EV; Pivnik AV; Shilin DE; Nasibov OM; Margolin OV; Pustovoĭt LA
Ter Arkh; 1997; 69(11):71-3. PubMed ID: 9483755
[TBL] [Abstract][Full Text] [Related]
13. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
Gleicher N; Weghofer A; Oktay K; Barad DH
Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
[TBL] [Abstract][Full Text] [Related]
14. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
15. Autotransplantation of ovarian tissue.
Baird D; Anderson R; Hamish Wallace W
Lancet; 2001 Aug; 358(9281):588. PubMed ID: 11526933
[No Abstract] [Full Text] [Related]
16. [Problems in the preservation of reproductive function in female patients after treatment for Hodgkin lymphoma].
Danilenko AA; Shakhmarina SV
Vopr Onkol; 2012; 58(3):320-6. PubMed ID: 22888645
[No Abstract] [Full Text] [Related]
17. Resumption of ovarian function 20 years after chemotherapy-induced ovarian failure: a case report.
Longway M; Matthews CA
Fertil Steril; 2009 Jul; 92(1):392.e17-8. PubMed ID: 19403127
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous premature ovarian failure: management challenges.
Kalu E; Panay N
Gynecol Endocrinol; 2008 May; 24(5):273-9. PubMed ID: 18569032
[TBL] [Abstract][Full Text] [Related]
19. Assisted reproduction and breast cancer.
Sonmezer M; Atabekoglu C
Minerva Ginecol; 2007 Aug; 59(4):403-14. PubMed ID: 17923831
[TBL] [Abstract][Full Text] [Related]
20. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
